{"slideshow_credits": null, "snippet": "A California initiative meant to lower skyrocketing prescription drug prices faces opposition from not only drug makers but also some patient advocacy groups....", "abstract": "Several patient advocacy groups have emerged as unlikely opponents of California ballot initiative aimed at reducing prescription drug prices; say plan will be difficult to implement and could inadvertently lead to higher prices as pharmaceutical companies seek to outmaneuver restrictions. ", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2016/07/05/business/california-drug-price-plan-is-criticized-by-patient-advocates.html", "lead_paragraph": "A California initiative meant to lower skyrocketing prescription drug prices faces opposition from not only drug makers but also some patient advocacy groups.", "headline": {"main": "California Drug Price Plan Is Criticized by Patient Advocates", "print_headline": "Drug Price Plan Has Surprising Opposition"}, "_id": "577ad2f738f0d83e1f65d6e2", "word_count": "1324", "multimedia": [{"height": 126, "url": "images/2016/06/30/business/01DRUGS/01DRUGS-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/06/30/business/01DRUGS/01DRUGS-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 399, "url": "images/2016/06/30/business/01DRUGS/01DRUGS-articleLarge.jpg", "legacy": {"xlarge": "images/2016/06/30/business/01DRUGS/01DRUGS-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "399"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/06/30/business/01DRUGS/01DRUGS-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/06/30/business/01DRUGS/01DRUGS-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-07-05T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "rank": "2"}, {"name": "glocations", "value": "California", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Referendums", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Health Insurance and Managed Care", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}